Viewing Study NCT03436732


Ignite Creation Date: 2025-12-24 @ 9:28 PM
Ignite Modification Date: 2026-05-04 @ 8:51 AM
Study NCT ID: NCT03436732
Status: TERMINATED
Last Update Posted: 2019-11-22
First Post: 2018-02-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mesothelioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotoxin View
None Rapamycin View
None Targeted Therapy View
None Mesothelin View